Silverback Therapeutics, Inc.
USD5.87
+0.06 (+1.03%)
CEO
Peter A. Thompson
IPO Date
2020-12-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.82
Prev. Close
$5.81
Day Low
$5.82
Day High
$6.15
52W Low
$2.80
52W High
$7.54
Market Cap
$0.55B
Volume
0.12M
| 300,000 |
| $5.58 |
| 4 Jan 2024 | Dorsey Brian | Chief Operating Officer | A-Award | Acquired | 350,000 | $5.58 |
| 2 Oct 2023 | Fitzpatrick Alexander A | Chief Legal Officer | P-Purchase | Acquired | 46,258 | $3.78 |
| 2 Oct 2023 | Fitzpatrick Alexander A | Chief Legal Officer | P-Purchase | Acquired | 40,000 | $3.62 |
| 25 Sept 2023 | RA CAPITAL MANAGEMENT, L.P. | director | P-Purchase | Acquired | 191,309 | $3.83 |
| 25 Sept 2023 | RA CAPITAL MANAGEMENT, L.P. | director | P-Purchase | Acquired | 2,508,691 | $2.97 |
| 5 Sept 2023 | Shawver Laura | director | M-Exempt | Acquired | 97,003 | $1.27 |
| 5 Sept 2023 | Shawver Laura | director | M-Exempt | Acquired | 2,997 | $1.27 |
| 5 Sept 2023 | Shawver Laura | director | S-Sale | Disposed | 100,000 | $7.71 |